Illumina INC:1107104 [18-002960]

Ended Awarded Last action

Contract number
HHSN26100070
Awardee
Awarding agency
Obligated
$6,893

Award facts

Opportunity
  • NIHNHLBICSBHG2015RF Solicitation number
Contract value 100% obligated
$6,892.55 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute issued a delivery order to Illumina, Inc. on October 23, 2017, with a ceiling value of $6,892.55. Place of performance is Bethesda, MD. The order is for genetic sequencing equipment, reagents, or consumables consistent with Illumina's portfolio of DNA and RNA sequencing instruments and bioinformatics software supporting genomic research. The ultimate completion date is November 19, 2017. The order is priced as firm fixed price with no set-aside designation.

Quick answers

Who was awarded contract HHSN26100070?

HHSN26100070 was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on October 23, 2017.

How much is contract HHSN26100070 worth?

The government has obligated $6,893 on HHSN26100070.

Is contract HHSN26100070 an order under another contract?

Yes. HHSN26100070 is a delivery order under HHSN268201500004I, an indefinite delivery contract.

Was contract HHSN26100070 competed?

The extent of competition for HHSN26100070 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award